Press Releases
- Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholarship Program03/23/2021
- Sarepta Therapeutics’ Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and Functional Improvements 2 Years After Administration03/18/2021
- Sarepta Therapeutics to Present Results from its Gene Therapy and RNA Platforms at the 2021 Annual MDA Clinical and Scientific Conference03/15/2021
News Features
Media Library
Press Contact
Tracy Sorrentino
Senior Director, Public Relations
Sarepta Therapeutics, Inc.
[email protected]
617-274-4052